Literature DB >> 18043225

Gastrointestinal microbiology enters the metagenomics era.

Daniel N Frank1, Norman R Pace.   

Abstract

PURPOSE OF REVIEW: Advances in DNA sequence-based technologies now permit genetic analysis of complex microbial populations without the need for prior cultivation. This review summarizes the molecular methods of culture-independent microbiology ('metagenomics') and their recent application to studies of the human gastrointestinal tract in both health and disease. RECENT
FINDINGS: Culture-independent metagenomic surveys reveal unprecedented microbial biodiversity in the human intestine. Upwards of 40,000 bacterial species are estimated to comprise the collective gastrointestinal microbiome, most of which have not been characterized by culture. Diverse conditions such as antibiotic-associated diarrhea, Crohn's disease, ulcerative colitis, obesity, and pouchitis have been correlated with large-scale imbalances in gastrointestinal microbiota, or 'dysbiosis'. These findings demonstrate the importance of commensal microorganisms in maintaining gastrointestinal health.
SUMMARY: Through technological and conceptual innovations in metagenomics, the complex microbial habitat of the human gastrointestinal tract is now amenable to detailed ecological analysis. Large-scale shifts in gut commensal populations, rather than occurrence of particular microorganisms, are associated with several gastroenterological conditions; redress of these imbalances may ameliorate the conditions.

Entities:  

Mesh:

Year:  2008        PMID: 18043225     DOI: 10.1097/MOG.0b013e3282f2b0e8

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  132 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Metagenomic analysis of the viromes of three North American bat species: viral diversity among different bat species that share a common habitat.

Authors:  Eric F Donaldson; Aimee N Haskew; J Edward Gates; Jeremy Huynh; Clea J Moore; Matthew B Frieman
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

3.  Enterocytes' tight junctions: From molecules to diseases.

Authors:  Stelios F Assimakopoulos; Ismini Papageorgiou; Aristidis Charonis
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

4.  Environmental factors associated with Crohn's disease in India-there's more to it than meets the eye.

Authors:  Anjan Dhar
Journal:  Indian J Gastroenterol       Date:  2011-12-02

5.  New approaches for isolation of previously uncultivated oral bacteria.

Authors:  M V Sizova; T Hohmann; A Hazen; B J Paster; S R Halem; C M Murphy; N S Panikov; S S Epstein
Journal:  Appl Environ Microbiol       Date:  2011-11-04       Impact factor: 4.792

Review 6.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 7.  Voices from within: gut microbes and the CNS.

Authors:  Paul Forsythe; Wolfgang A Kunze
Journal:  Cell Mol Life Sci       Date:  2012-05-27       Impact factor: 9.261

Review 8.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

9.  Tools for the tract: understanding the functionality of the gastrointestinal tract.

Authors:  Petia Kovatcheva-Datchary; Erwin G Zoetendal; Koen Venema; Willem M de Vos; Hauke Smidt
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

10.  Abrupt temporal fluctuations in the chicken fecal microbiota are explained by its gastrointestinal origin.

Authors:  M Sekelja; I Rud; S H Knutsen; V Denstadli; B Westereng; T Næs; K Rudi
Journal:  Appl Environ Microbiol       Date:  2012-02-03       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.